You are leaving and being redirected to www.sanofi.us, our parent company, where all product inquiries are handled.
Genzyme Oncology Pipeline
| Research | Preclinical | Phase 1 | Phase 2 | Phase 3 | Postmarketing Studies | |
| HEMATOLOGIC ONCOLOGY | ||||||
| Campath combination CLL |
|
|
|
|
 |
|
| Prochymal graft vs. host disease |
|
|
|
|
|
|
| Clolar combination adult rel/ref AML |
|
|
|
|
|
|
| Clolar adult AML |
|
|
|
|
||
| Thymoglobulin myelodysplastic syndromes |
|
|
|
|
||
| Mozobil tumor sensitization |
|
|
|
|
||
| Clolar combination pediatric rel/ref ALL and AML |
|
|
|
|
||
| Clolar oral myelodysplastic syndromes |
|
|
|
|||
| GC1008 solid tumors |
|
|
|
|||